Brief: UCB Presents New Data Demonstrating Quality-Of-Life Impacts For Epilepsy Patients And Caregivers At Aan 2026 Meeting
15/04/2026 06:04
April 15 (Reuters) - Ucb SA UCB.BR: UCB PRESENTS NEW DATA DEMONSTRATING QUALITY-OF-LIFE IMPACTS FOR EPILEPSY PATIENTS AND CAREGIVERS AT AAN 2026 MEETING ANALYSIS DATA SHOW REDUCTIONS IN HEALTHCARE RESOURCE UTILIZATION AND ANTISEIZURE MEDICATION CLAIMS FOR PATIENTS WITH TREATMENT PERSISTENCE AT 6 AND 12 MONTHS Source text: nPLXF093FE Further company coverage: UCB.BR (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on UCB SA
See all newsAnalysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Brief: UCB Announces Data Showing Positive Impact Of Kygevvi In Tk2d Patients
Brief: UCB Completes $2.2 Billion Acquisition Of Candid Therapeutics
Europe Research Roundup: Banca Generali, Ferrari, Prysmian
Barclays downgrades UCB after rally, sees limited upside